Who is sponsoring NCT04292639?

NCT04292639 is sponsored by Vital USA, Inc..

What drugs are being tested in NCT04292639?

Interventions in NCT04292639: The Vital Detect Pulse Oximeter.

What condition does NCT04292639 study?

NCT04292639 studies Respiratory Complication.

Is NCT04292639 still recruiting?

NCT04292639 is currently completed. Last updated 28 May 2020.

Are results published for NCT04292639?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2020-05-28 · How we verify

NCT04292639: RR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vital USA Respiratory Rate Validation In Adults

Completed NA Results posted Last updated 28 May 2020

What this trial tests

NA trial testing The Vital Detect Pulse Oximeter in Respiratory Complication in 20 participants. Completed in 20 December 2019.

Timeline

17 December 2019

Primary endpoint
20 December 2019

20 December 2019

Quick facts

Lead sponsor	Vital USA, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	20
Start date	17 December 2019
Primary completion	20 December 2019
Estimated completion	20 December 2019
Sites	1 location across United States

Drugs / interventions tested

The Vital Detect Pulse Oximeter

Conditions studied

Respiratory Complication — all drugs for Respiratory Complication →

Sponsor

Vital USA, Inc.

Who can join

Adults 18 to 52, any sex, with Respiratory Complication. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Respiratory Rate Accuracy Validation for the Vital USA Vital Detect Monitor. Primary · 20 Seconds

The primary objective of this study was to compare the accuracy of device under test for the measurement of respiratory rate. The respiratory rate was measured simultaneously with EtCO2 (Reference) and the Vital USA Vital Detect monitor (Device Under Test).The endpoint of interest was accuracy as measured by the Accuracy root-mean-square (ARMS) difference between the Device Under Test (DUT) and the reference respiratory rate system (Ref) for all stable respiratory periods.

Group	Value	95% CI
Respiratory Rate	1.39	± 1.39

Sponsor's own description

Vital USA is dedicated to developing and applying innovative electronic medical solutions that improve patient care in multiple clinical settings. Vital USA is a manufacturer of a multi-parameter patient monitor that is intended to be used in a variety of medical settings including hospitals, medical offices and patients' homes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Respiratory Complication

Currently open trials in the same condition.

NCT06443515 — Respiratory Trends During Blood Transfusions in Newborns. · NA · recruiting
NCT06412081 — Lung Ultrasound for Physiotherapy in Hospitalized Patients With Respiratory Complications · recruiting
NCT06301126 — Virtual Reality on Pulmonary Function After Upper Abdominal Surgeries · NA · active not recruiting
NCT06744790 — Advanced Prediction of Respiratory Depression Episode Using the Linshom Continuous Predictive Respiratory Sensor · recruiting
NCT05856136 — A Study to Investigate of the Effects of Opioid Exposure on the Ability of the Diaphragm Muscle · Phase 4 · recruiting

Other Vital USA, Inc. trials

Trials by the same sponsor.

NCT04296227 — Comparison of Non-Invasive Blood Pressure Methods · NA · completed
NCT04285411 — Vital USA SpO2 Accuracy Comparison to Arterial Blood CO-Oximetry · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04292639 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Vital USA, Inc.
Last refreshed: 28 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04292639.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing